Want to join the conversation?
Excluding merger-related costs expected in 4Q16, $SNV expects the Entaire acquisition to immediately add to EPS, ROE, and ROA. Entaire's key management has signed long-term employment agreements with $SNV. Transaction is expected to close in start of 4Q16. Barclays served as financial advisor to $SNV in this transaction.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?